People
Chris Freeman
Cyted appointed Freeman as an adviser on US commercial growth in January 2025. The appointment described his commercial leadership at Guardant Health and earlier work at Gilead, Elan and Genentech; current advisory status is unverified.
Roles
Cyted Health
CurrentStrategic adviser (published appointment; current membership unverified)